Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/214407
Title: | Exploring the Associations of Inflammatory and Oxidative Stress Biomarkers with Pancreatic Diseases: An Observational and Mendelian Randomisation Study |
Author: | Vilà-quintana, Laura Fort, Esther Pardo, Laura Albiol-quer, Maria T. Ortiz, Maria Rosa Capdevila, Montserrat Feliu, Anna Bahí, Anna Llirós, Marc Aguilar, Esther García-velasco, Adelaida Ginestà, Mireia M. Laquente, Berta Pozas, Débora Lluansí, Aleix Pimenoff, Ville Nikolai Moreno, Victor Garcia-gil, Libadro Jesús Duell, Eric J. Carreras-torres, Robert Aldeguer, Xavier |
Issue Date: | 12-Apr-2024 |
Publisher: | MDPI AG |
Abstract: | Identifying biomarkers linked to pancreatic ductal adenocarcinoma (PDAC) and chronic pancreatitis (CP) is crucial for early detection, treatment, and prevention. Methods: Association analyses of 10 serological biomarkers involved in cell signalling (IFN-gamma, IL-6, IL-8, IL-10), oxidative stress (superoxide dismutase (SOD) and glutathione peroxidase (GPx) enzyme activities, total glutathione (GSH), malondialdehyde (MDA) levels), and intestinal permeability proteins (zonulin, I-FABP2) were conducted across PDAC (n = 12), CP (n = 21) and control subjects (n = 23). A Mendelian randomisation (MR) approach was used to assess causality of the identified significant associations in two large genetic cohorts (FinnGen and UK Biobank). Results: Observational results showed a downregulation of SOD and GPx antioxidant enzyme activities in PDAC and CP patients, respectively, and higher MDA levels in CP patients. Logistic regression models revealed significant associations between CP and SOD activity (OR = 0.21, 95% CI [0.05, 0.89], per SD), GPx activity (OR = 0.28, 95% CI [0.10, 0.79], per SD), and MDA levels (OR = 2.05, 95% CI [1.36, 3.08], per SD). MR analyses, however, did not support causality. Conclusions: These findings would not support oxidative stress-related biomarkers as potential targets for pancreatic diseases prevention. Yet, further research is encouraged to assess their viability as non-invasive tools for early diagnosis, particularly in pre-diagnostic CP populations. |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/jcm13082247 |
It is part of: | Journal of Clinical Medicine, 2024, vol. 13, issue. 8, p. 2247 |
URI: | http://hdl.handle.net/2445/214407 |
Related resource: | https://doi.org/10.3390/jcm13082247 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
jcm-13-02247.pdf | 694.26 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.